Literature DB >> 16566078

Low-grade gliomas: the debate continues.

Paul D Brown1.   

Abstract

Low-grade gliomas (LGG) are a heterogeneous group of tumors that tend to occur primarily in young adults and children. They are indolent, progressive, and often undergo anaplastic transformation. The prognosis of these tumors is primarily affected by age and pathologic type. Many questions remain in the management of LGGs, including the role of surgical resection (ie, maximal tumor resection), the optimal timing of radiation (ie, postoperative vs at the time of tumor progression), and the role of chemotherapy (ie, salvage after radiotherapy, primary treatment after surgery, concurrent with radiotherapy). Further complicating treatment decisions are concerns about toxicity with any intervention because LGG patients can often lead a relatively normal existence for years with no intervention. In this article we review the pertinent LGG literature published over the past few years and its impact on the management of LGGs.

Entities:  

Mesh:

Year:  2006        PMID: 16566078     DOI: 10.1007/s11912-006-0012-x

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  47 in total

1.  Temozolomide: too early for definitive conclusions.

Authors:  Paul Brown; Jan Buckner
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

2.  A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results.

Authors:  M C Vigliani; N Sichez; M Poisson; J Y Delattre
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-06-01       Impact factor: 7.038

3.  Suspected low-grade glioma: is deferring treatment safe?

Authors:  L D Recht; R Lew; T W Smith
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

4.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

Review 5.  Cognitive sequelae of brain radiation in adults.

Authors:  Nadia N Laack; Paul D Brown
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

6.  MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.

Authors:  M D Jenkinson; T S Smith; K Joyce; D Fildes; D G du Plessis; P C Warnke; C Walker
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

7.  Magnetic resonance image registration and subtraction in the assessment of minor changes in low grade glioma volume.

Authors:  S E J Connor; R Gunny; T Hampton; R O'gorman
Journal:  Eur Radiol       Date:  2004-07-14       Impact factor: 5.315

8.  Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas.

Authors:  Chiaki Komine; Takao Watanabe; Yoichi Katayama; Atsuo Yoshino; Takakazu Yokoyama; Takao Fukushima
Journal:  Brain Pathol       Date:  2003-04       Impact factor: 6.508

9.  Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.

Authors:  A Pace; A Vidiri; E Galiè; M Carosi; S Telera; A M Cianciulli; P Canalini; D Giannarelli; B Jandolo; C M Carapella
Journal:  Ann Oncol       Date:  2003-12       Impact factor: 32.976

10.  Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

Authors:  K Hoang-Xuan; L Capelle; M Kujas; S Taillibert; H Duffau; J Lejeune; M Polivka; E Crinière; Y Marie; K Mokhtari; A F Carpentier; F Laigle; J M Simon; P Cornu; P Broët; M Sanson; J Y Delattre
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

View more
  5 in total

Review 1.  Pilomyxoid astrocytoma of the cervical spinal cord in a child with rapid progression into glioblastoma: case report and literature review.

Authors:  Dimitrios Paraskevopoulos; Ioannis Patsalas; Georgios Karkavelas; Nikolaos Foroglou; Ioannis Magras; Panagiotis Selviaridis
Journal:  Childs Nerv Syst       Date:  2010-05-12       Impact factor: 1.475

2.  Malignant glioblastomatous transformation of a low-grade glioma in a child.

Authors:  Ekrem Unal; Yavuz Koksal; Omer Cimen; Yahya Paksoy; Lema Tavli
Journal:  Childs Nerv Syst       Date:  2008-10-01       Impact factor: 1.475

3.  MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas.

Authors:  A Lasocki; A Tsui; M A Tacey; K J Drummond; K M Field; F Gaillard
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-07       Impact factor: 3.825

4.  Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors.

Authors:  Anna Mucha-Małecka; Bogdan Gliński; Marcin Hetnał; Magdalena Jarosz; Jacek Urbański; Beata Frączek-Błachut; Paweł Dymek; Krzysztof Małecki; Agnieszka Chrostowska
Journal:  Rep Pract Oncol Radiother       Date:  2012-02-10

5.  Long-Term Results of stereotactic Brachytherapy (Temporary 125Iodine Seeds) for the Treatment of Low-Grade Astrocytoma (Grade II).

Authors:  Sohrab Shahzadi; Parisa Azimi; Khosrow Parsa
Journal:  Iran Red Crescent Med J       Date:  2013-01-05       Impact factor: 0.611

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.